1.Cerebral Infarction in an Elderly Patient during Dabigatran Treatment
Yuji Nishizaki ; Shinichiro Yamagami ; Hitoshi Sasano ; Eiryu Sai ; Kazuhisa Takamura ; Toshiki Nakahara ; Yoshiaki Furukawa ; Hiroyuki Daida
General Medicine 2015;16(1):41-44
A 91 year-old male who was orally receiving dabigatran and digitalis for chronic arterial fibrillation was hospitalized for cerebral infarction (CI). The complications of anemia due to gastrointestinal bleeding and the development of renal failure were also found, which enhanced the effect of digitalis. This enhanced drug action induced bradycardia and hypotension. The hypotension was improved by implanting a temporary pacemaker, and the neurological abnormal findings also disappeared with the improved blood pressure. In many cases, dabigatran is efficient in preventing CI, but in our case it in fact triggered a CI hemodynamically due to bradycardia and hypotension with gastrointestinal bleeding.
2.Potential Psychosis Induced by a Sustained High Plasma Levodopa Concentration Due to Continuous Subcutaneous Foslevodopa/Foscarbidopa Infusion in a Patient With Parkinson’s Disease: A Case Report
Toshiki TEZUKA ; Tomonori NUKARIYA ; Yuta KIZUKA ; Shohei OKUSA ; Ryotaro OKOCHI ; Yuto SAKAI ; Yoshihiro NIHEI ; Jin NAKAHARA ; Morinobu SEKI
Journal of Movement Disorders 2024;17(4):453-455
3.Potential Psychosis Induced by a Sustained High Plasma Levodopa Concentration Due to Continuous Subcutaneous Foslevodopa/Foscarbidopa Infusion in a Patient With Parkinson’s Disease: A Case Report
Toshiki TEZUKA ; Tomonori NUKARIYA ; Yuta KIZUKA ; Shohei OKUSA ; Ryotaro OKOCHI ; Yuto SAKAI ; Yoshihiro NIHEI ; Jin NAKAHARA ; Morinobu SEKI
Journal of Movement Disorders 2024;17(4):453-455
4.Potential Psychosis Induced by a Sustained High Plasma Levodopa Concentration Due to Continuous Subcutaneous Foslevodopa/Foscarbidopa Infusion in a Patient With Parkinson’s Disease: A Case Report
Toshiki TEZUKA ; Tomonori NUKARIYA ; Yuta KIZUKA ; Shohei OKUSA ; Ryotaro OKOCHI ; Yuto SAKAI ; Yoshihiro NIHEI ; Jin NAKAHARA ; Morinobu SEKI
Journal of Movement Disorders 2024;17(4):453-455
5.Potential Psychosis Induced by a Sustained High Plasma Levodopa Concentration Due to Continuous Subcutaneous Foslevodopa/Foscarbidopa Infusion in a Patient With Parkinson’s Disease: A Case Report
Toshiki TEZUKA ; Tomonori NUKARIYA ; Yuta KIZUKA ; Shohei OKUSA ; Ryotaro OKOCHI ; Yuto SAKAI ; Yoshihiro NIHEI ; Jin NAKAHARA ; Morinobu SEKI
Journal of Movement Disorders 2024;17(4):453-455